DJ Drucker, MA Nauck - The Lancet, 2006 - Elsevier Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that
stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying,
and reduces appetite and food intake. Therapeutic approaches for enhancing ... Cited by 408 - Related articles - All 10 versions
- ►wanfang.gov.tw [DOC] RE Amori, J Lau, AG Pittas - Jama, 2007 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 240 - Related articles - BL Direct - All 8 versions
- Free from Publisher B Ahrén, G Pacini, JE Foley, A Schweizer - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—In subjects completing 52 weeks with participation in all meal tests
(n = 57), HbA 1c (A1C) decreased in the vildagliptin/metformin group (VM group,
n = 31) but increased in the placebo/metformin group (PM group, n = 26; ... Cited by 176 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org E Bosi, RP Camisasca, C Collober, E … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—The between-treatment difference (vildagliptin − placebo) in
adjusted mean change (AMΔ) ± SE in A1C from baseline to end point was −0.7
± 0.1% (P < 0.001) and −1.1 ± 0.1% (P < 0.001) in patients receiving 50 ... Cited by 147 - Related articles - BL Direct - All 10 versions
- Free from Publisher J Rosenstock, MA Baron, S Dejager, D Mills, … - Diabetes Care, 2007 - ncbi.nlm.nih.gov OBJECTIVE: To compare the efficacy and tolerability of vildagliptin and
rosiglitazone during a 24-week treatment in drug-naïve patients with type 2
diabetes. RESEARCH DESIGN AND METHODS: This was a double-blind, randomized, ... Cited by 142 - Related articles - BL Direct - All 5 versions
S Ristic, S Byiers, J Foley, D Holmes - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 138 - Related articles - BL Direct - All 4 versions
D Holmes - Horm Metab Res, 2006 - rima.org The incretin hormones ± glucose−dependent insulinotropic poly− peptide
(GIP) and particularly glucagon−like peptide−1 (GLP−1) ± have been
reported to exert multiple metabolic effects that con− tribute to the ... Cited by 119 - Related articles - View as HTML - BL Direct - All 4 versions
GA Herman, C Stevens, K Van Dyck, A … - Clinical Pharmacology & Therapeutics, 2005 - nature.com Background: Sitagliptin (MK-0431 [(2R)-4-oxo-4-(3-[trifluoromethyl]-5,6-dihydro[
1,2,4]triazolo[4,3-a]pyrazin-7[8H]-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine])
is an orally active, potent, and selective inhibitor of dipeptidyl ... Cited by 115 - Related articles - All 6 versions
J Rosenstock, MA Baron, R Camisasca, F … - Diabetes, Obesity and Metabolism, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 109 - Related articles - All 5 versions
- ►physiology.org JJ Holst - Physiological reviews, 2007 - Am Physiological Soc Glucagon-like peptide 1 (GLP-1) is a 30-amino acid peptide hormone produced in
the intestinal epithelial endocrine L-cells by differential processing of
proglucagon, the gene which is expressed in these cells. The current ... Cited by 113 - Related articles - BL Direct - All 5 versions
